Work

2′-fucosyllactose and Akkermansia muciniphila as a candidate synergistic synbiotic: mechanisms for gut health and immune modulation

Year: 2026
Type: article
Abstract: The dynamic interplay between dietary glycans and commensal microorganisms fundamentally shapes host–microbiota homeostasis and immune regulation. This review examines the pairing of 2′-fucosyllactose (2′-FL), a predominant human milk oligosaccharide (HMO), and A. muciniphila , a mucin-degrading next-generation probiotic. We synthesize mechanistic evidence that 2′-FL can enrich A. muciniphila colonization and metabolic output in experimental systems. Most of this evidence is derived from in vitro and animal studies, whereas human evidence is limited to single-component interventions with either 2′-FL or A. muciniphila . Direct co-administration evidence remains limited: in a mouse colitis study from our group, co-administering 2′-FL with A. muciniphila enhanced anti-inflammatory effects and short-chain fatty acid production beyond bacterial monocolonization, and an independent mouse study reported improved colonization and colitis outcomes with combined administration. However, neither study reported formal statistical interaction testing, the synergistic finding awaits independent replication, and no human combination trial has been conducted. Accordingly, the proposed synergistic mechanisms remain provisional, and the efficacy of this candidate synbiotic requires validation in controlled combination experiments and human studies. This substrate–microbe axis may influence mucin-related and epithelial barrier functions and contribute to immune homeostasis through preparation- and context-dependent mechanisms. Furthermore, we critically evaluate translational implications for developing synbiotic functional food formulations, including effective dosing in adult populations, bioavailability, formulation stability, and safety considerations. By integrating nutritional glycobiology with microbiome science and probiotic technology, this work proposes a comprehensive conceptual framework for microbiota-based immune modulation and evidence-based functional food innovation.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236775308
FWCI:
Cites: 71
Cited by:
Related to: 10